Following the conclusion that the Republicans would win the presidency and a majority in both chambers of parliament, we decided at an extraordinary investment committee meeting at the beginning of November to further increase our overweight position in the US equity market, at the expense of liquidity in the corresponding reference currencies.
At our most recent Investment Committee meeting, the following asset allocation of a balanced Swiss franc portfolio with a medium risk level, without client restrictions, was agreed. It should be noted that mandates in other reference currencies may have different changes and weightings. Should you wish to inquire about these, please feel free to contact your client advisor.
Money market
We have reduced the overweight of liquidity in our balanced portfolios. This has been achieved in connection with the increase in the equity allocation and the purchase of the Plenum European Insurance Bond Fund. We are now fully invested.
Bonds
The yield advantage of USD bonds over their CHF counterparts widened during the period under review because of the stronger interest rate cuts by the SNB. We are retaining a 4% allocation to USD bonds as part of the asset allocation and due to the appreciation of the USD, investors with CHF as their reference currency also benefit from currency gains. As an admixture and to increase returns, our strategy involves focusing on two distinctive funds within this asset class, which have delivered convincing returns since the beginning of the year (see also Table 4 "Other funds we use").
Other funds in which we have invested in have performed as follows:

Equities Switzerland
We remain slightly underweight in Swiss equities compared to our strategic focus. The Swiss Performance Index (SPI) lost 4.7% over the last three-month period. In the last quarter, we sold the shares of Swatch and Vetropack and used the proceeds to increase our holdings in Tecan, Richemont and Nestlé. Our stock selection based on value criteria, the "Swiss Stock Portfolio" (SSP), posted an overall performance (price changes plus dividends) of -4.6% in the third quarter and slightly outperformed its benchmark. Compared to the benchmark, we hold a larger weighting of Swiss equities from the small and mid-cap segment, which usually leads to deviations from the SPI.
Particularly strong performers in the SSP over the last quarter were Galderma (+28%), EFG (+16%) and Swissquote (+14%). The worst performers were Tecan (-24%), Barry Callebaut (-23%) and Zehnder (-18%).
The price/earnings ratios, based on the most recently known twelve months earnings, are developing unevenly: 
Over the long term, the SSP has performed very well. Since 2012, its average annual performance has been 9.74%, significantly outperforming the average benchmark performance of 7.89%. Since 2012, our strategy has generated a cumulative total performance of around 267%, compared with 190% for the index. Transaction costs are deducted from the SSP figures, while the benchmark index is calculated free of charge.
Equities Europe
Domestic political problems in Germany and France and years of over-regulation are putting pressure on European equity markets. In the fourth quarter the broad Stoxx 600 Europe NR fell by 3.2%, while the Euro Stoxx 50, which includes the 50 largest stocks from the EUR currency area, fell by 2.4%.
In our European stock selection, we sold shares in Orange, SEB, Deutsche Post and Volkswagen due to the uncertain situation in France and Germany. We made corresponding replacement investments in the shares of Moncler, HSBC, ASML (increase), Enel and Nestlé. Despite the tactical adjustments mentioned above, our European stock selection was unable to make up for the shortfall against the benchmark in the previous quarters. In the fourth quarter, the ESP lost 4.5% and underperformed its benchmark.
Price / book value and dividend yield of major stock markets:

The best performing European stocks in the last quarter were Tenaris (+30%), Moncler (7%) and HSBC Holdings (+5%). At the bottom of the share price table were Capgemini (-19%), Novo Nordisk (-21%) and DSM-Firmenich (-21%). Figures are shown in the respective local currencies.
As a keen reader of our Investment Report, you will have noticed that there is no information on the long-term performance of the European Stock Portfolio (ESP).
Having reviewed our long-term European equity selection process, we have decided to make certain adjustments. The previous value-oriented approach focused on undervalued stocks and led to an overweight in small- and mid-capitalised companies relative to the benchmark. The new selection process expands the investment universe to include growth, quality and large-cap stocks and incorporates other qualitative factors and technical analyses into the five-stage process. More flexible rebalancing and the increased use of ETFs should enable us to respond quickly to market changes. The new approach will reduce our dependence on any particular investment style.
Equities US
In the fourth quarter, the rally in US equities continued with the tailwind of the US election result. We tactically increased our US equity selection by investing in two funds on the Nasdaq 100 and the Russell 2000 index. We believe that technology companies in the Nasdaq 100 and small and mid-cap US companies from the Russell 2000 Index will benefit more than average from Trump's policies.
Equities Asia (excluding Japan)
We have not made any changes to our investments in mainland Asia since our last report. In addition to our long-standing position in the equity fund Barings Asean Fund, which holds equities from emerging countries in Southeast Asia, we are invested in Indian and Vietnamese equities through two country funds. We are slightly overweight in this investment region.
Equities Japan
The Bank of Japan (BOJ) shocked investors with a small interest rate hike at the end of July. Since then, the BOJ has remained on hold and the Japanese equity market has continued its recovery. We believe a neutral weighting in Japanese equities is appropriate
Alternative Investments
We are currently underrepresented in alternative investments compared to the strategic weighting and are only invested in the AXA Cat Bonds Fund. This fund invests in bonds that reinsure clearly defined natural catastrophe losses. Although some losses during the hurricane season had a slightly negative impact on the fund's return, the risks were very well compensated for by the attractive premiums. The fund closed the year with a positive return.
Our asset allocation in summary:
